Praxis Precision Medicines, Inc.(PRAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PRAX Praxis Precision Medicines, Inc.

Pre-Mkt 10-28 06:44:20 EDT

267.59

+0.20

+0.07%

High272.20	Low266.11	Vol388.22K
Open267.35	D1 Closing267.39	Amplitude2.28%
Mkt Cap7.45B	Tradable Cap6.44B	Total Shares27.85M
T/O104.21M	T/O Rate1.61%	Tradable Shares24.08M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PRAX","market":"US","secType":"STK","nameCN":"Praxis Precision Medicines, Inc.","latestPrice":267.59,"timestamp":1793131200000,"preClose":267.39,"halted":0,"volume":388222,"delay":0,"changeRate":0.0007479711283144046,"floatShares":24076500,"shares":27850833,"eps":-12.863398,"marketStatus":"Pre-Mkt","change":0.2,"latestTime":"10-28 06:44:20 EDT","open":267.35,"high":272.2,"low":266.11,"amount":104210214.05568,"amplitude":0.022776,"askPrice":271.3,"askSize":1,"bidPrice":265.5,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-12.863398,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1793194200000},"marketStatusCode":1,"adr":0,"listingDate":1602820800000,"exchange":"NASDAQ","adjPreClose":267.59,"postHourTrading":{"tag":"盘后","latestPrice":273.4641,"preClose":267.59,"latestTime":"19:36 EDT","volume":9571,"amount":2562403.9605,"timestamp":1793144195200,"change":5.8741,"changeRate":0.021952,"amplitude":0.021952},"volumeRatio":0.7763968572068375,"impliedVol":1.0612,"impliedVolPercentile":0.928},"requestUrl":"/m/hq/s/PRAX","defaultTab":"news","newsList":[{"id":"2678488558","title":"Praxis Precision Medicines Updates Financial Calendar","url":"https://stock-news.laohu8.com/highlight/detail?id=2678488558","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678488558?lang=en_us&edition=fundamental","pubTime":"2026-10-28 04:01","pubTimestamp":1793131306,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines updates financial calendarPraxis Precision Medicines will report third-quarter 2026 financial results before markets open Nov. 9, 2026.Investor Day in New York starts Nov. 1","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261027:nNDLbYKsk4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE0009355771.USD","IE00BQXX3D17.EUR","IE00B64PRP62.GBP","IE00BJT1NW94.SGD","IE00BQXX3C00.GBP","LU0109394709.USD","IE00B2B36J28.USD","IE00BGHQF748.EUR","IE00BJJMRZ35.SGD","LU0314104364.USD","BCDF","BK4585","IE00BN0W2W23.USD","SG9999014005.SGD","SG9999014013.SGD","IE00B3QW5Z07.USD","IE00BQXX3F31.USD","LU0889565916.HKD","LU0320765992.SGD","IE00B4R5TH58.HKD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","LU2210149790.SGD","IE00BFTCPJ56.SGD","SG9999014021.USD","IBRN","LU2095319765.USD","BK4112","LU2210150020.SGD","PRAX","IE0002141913.USD","BK4588","NDAQ","SG9999014039.USD","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678488921","title":"Praxis Precision Medicines Announces Third Quarter 2026 Financial Results Date, Investor Day and November Conference Participation","url":"https://stock-news.laohu8.com/highlight/detail?id=2678488921","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678488921?lang=en_us&edition=fundamental","pubTime":"2026-10-28 04:01","pubTimestamp":1793131260,"startTime":"0","endTime":"0","summary":"Company to host an in-person and virtual Investor Day on November 12, 2026BOSTON, Oct.  27, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading centra","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/27/3389586/0/en/praxis-precision-medicines-announces-third-quarter-2026-financial-results-date-investor-day-and-november-conference-participation.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNS","LU0109394709.USD","LU0889565916.HKD","IE00BFTCPJ56.SGD","BK4135","IE00B4R5TH58.HKD","LU0320765992.SGD","IE00B2B36J28.USD","BK4139","PRAX","IE0009355771.USD","IE00BJJMRZ35.SGD","IBRN","IE0002141913.USD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677607411","title":"3 ‘Strong Buy’ High-Risk Stocks with Double-Gain Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2677607411","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677607411?lang=en_us&edition=fundamental","pubTime":"2026-10-22 04:39","pubTimestamp":1792615173,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines ($PRAX), Quantinuum ($QNT), and Galaxy Digital ($GLXY) are three high-risk, high-reward stocks analysts recommend watchi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/3-strong-buy-high-risk-stocks-with-double-gain-potential?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/3-strong-buy-high-risk-stocks-with-double-gain-potential?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRAX","LU0109394709.USD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","BK4139","LU0889565916.HKD","IE0002141913.USD","IE00B2B36J28.USD","IE0009355771.USD","LU0320765992.SGD","IE00BFTCPJ56.SGD","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113339016","title":"Movement Alert｜Praxis Precision Medicines, Inc. Intraday Rise 5.2%, FDA Grants Breakthrough Therapy Designation to elsunersen","url":"https://stock-news.laohu8.com/highlight/detail?id=1113339016","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113339016?lang=en_us&edition=fundamental","pubTime":"2026-10-19 23:53","pubTimestamp":1792425236,"startTime":"0","endTime":"0","summary":"On October 19, Praxis Precision Medicines, Inc. rose 5.2% in Regular Trading, trading at $253.65 per share, with turnover of $28.85 million.The move followed the company’s disclosure that the FDA...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"FDA Breakthrough Therapy Designation Lifts Praxis Stock","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113581455","title":"Movement Alert｜Praxis Precision Medicines, Inc. Pre-Market Rise 5.48% in Pre-Market Trading, FDA Grants Breakthrough Therapy Designation to elsunersen","url":"https://stock-news.laohu8.com/highlight/detail?id=1113581455","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113581455?lang=en_us&edition=fundamental","pubTime":"2026-10-19 16:25","pubTimestamp":1792398317,"startTime":"0","endTime":"0","summary":"On October 19, Praxis Precision Medicines, Inc. rose 5.48% in Pre-Market Trading, trading at 255.0 USD/share, with turnover of 64.2 thousand USD.The move followed the company’s disclosure that the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Pre-Market Rise on FDA Breakthrough Therapy for elsunersen","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676524266","title":"Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX) and Madrigal Pharmaceuticals (MDGL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2676524266","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676524266?lang=en_us&edition=fundamental","pubTime":"2026-10-18 17:30","pubTimestamp":1792315829,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Praxis Precision Medicines (PRAX) and Madrigal Pharmaceuticals (M...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-praxis-precision-medicines-prax-and-madrigal-pharmaceuticals-mdgl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-praxis-precision-medicines-prax-and-madrigal-pharmaceuticals-mdgl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","XBI","BK4588","IE0002141913.USD","LU0109394709.USD","IE00B2B36J28.USD","IBRN","LABU","HCSG","LU0889565916.HKD","BK4585","IE00BJT1NW94.SGD","LU0320765992.SGD","XLV","LU2324357040.USD","PRAX","IE00BJJMRZ35.SGD","LU0128526141.USD","BK4581","BK4137","BK4139","LU0029874061.USD","MDGL","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675356135","title":"Praxis Precision Medicines, Inc. : JP Morgan Initiates Coverage with Overweight Rating; Price Target $700","url":"https://stock-news.laohu8.com/highlight/detail?id=2675356135","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675356135?lang=en_us&edition=fundamental","pubTime":"2026-10-16 15:25","pubTimestamp":1792135542,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261016:nFWN4620X7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009355771.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","IE0002141913.USD","LU0109394709.USD","BK4139","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU0889565916.HKD","PRAX","IE00B4R5TH58.HKD","LU0320765992.SGD","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675580265","title":"Praxis Precision Med Initiated at Buy by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2675580265","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675580265?lang=en_us&edition=fundamental","pubTime":"2026-10-16 05:43","pubTimestamp":1792100580,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRAX/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","PRAX","IBRN","LU0889565916.HKD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","IE0002141913.USD","LU0320765992.SGD","IE00BJT1NW94.SGD","LU0109394709.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675558165","title":"UBS Initiates Praxis Precision Medicines at Buy With $706 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2675558165","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675558165?lang=en_us&edition=fundamental","pubTime":"2026-10-15 19:41","pubTimestamp":1792064491,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines (PRAX) has an average rating of buy and mean price target of $647.50, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fr","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675210373","title":"Praxis Precision initiated with a Buy at UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2675210373","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675210373?lang=en_us&edition=fundamental","pubTime":"2026-10-15 08:00","pubTimestamp":1792022416,"startTime":"0","endTime":"0","summary":"UBS initiated coverage of Praxis Precision (PRAX) with a Buy rating and $706 price target The company has one of the most important biotech catalys...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/praxis-precision-initiated-with-a-buy-at-ubs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/praxis-precision-initiated-with-a-buy-at-ubs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B4R5TH58.HKD","PRAX","BK4139","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0320765992.SGD","IBRN","NVIB","IE0009355771.USD","IE00BFTCPJ56.SGD","XBIX","LU0109394709.USD","IE0002141913.USD","LU0889565916.HKD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675373215","title":"Praxis Precision Medicines (PRAX) Receives a New Rating from a Top Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2675373215","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675373215?lang=en_us&edition=fundamental","pubTime":"2026-10-15 07:55","pubTimestamp":1792022145,"startTime":"0","endTime":"0","summary":"In a report released today, Joon Lee from Truist Financial initiated coverage with a Buy rating on Praxis Precision Medicines and a price target of...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/praxis-precision-medicines-prax-receives-a-new-rating-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/praxis-precision-medicines-prax-receives-a-new-rating-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674877476","title":"High Growth Tech Stocks To Watch In US October 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2674877476","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674877476?lang=en_us&edition=fundamental","pubTime":"2026-10-12 19:08","pubTimestamp":1791803283,"startTime":"0","endTime":"0","summary":"The United States market has shown a steady performance, remaining flat over the last week but up 15% over the past year, with earnings forecasted to grow by 18% annually. In this environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation and adaptability to capitalize on these favorable conditions.","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/8111000-choice1-card/1788960394114","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/8111000-choice1-card/1788960394114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/tech/nyse-cien/ciena/news/high-growth-tech-stocks-to-watch-in-us-october-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/tech/nyse-cien/ciena/news/high-growth-tech-stocks-to-watch-in-us-october-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00B2B36J28.USD","LU2357305700.SGD","CIEN","BK4020","IE0002141913.USD","LU0823421416.USD","TGTX","IE00BJJMRZ35.SGD","FOTO","LU0963586101.USD","LU0889565916.HKD","IE0009355771.USD","CIEX","LU0205194284.USD","LU1720051108.HKD","LU0240878834.USD","PRAX","CIEG","LU0320765992.SGD","LU0719512351.SGD","LU0240877869.USD","LU0823421333.USD","LU1720051017.SGD","LU0106261612.USD","LU0154236417.USD","IE00BFTCPJ56.SGD","LU1989764664.SGD","BK4588","LU0012050646.USD","BK4585","LU0154245673.USD","BK4515","LU0082616367.USD","LU0348723411.USD","LU1548497426.USD","LU0205193047.USD","IE00B4R5TH58.HKD","IBRN","XTL","LU0154245756.USD","LU0109394709.USD","BK4139","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673055452","title":"Praxis Precision price target raised to $826 from $810 at BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2673055452","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673055452?lang=en_us&edition=fundamental","pubTime":"2026-10-06 19:31","pubTimestamp":1791286309,"startTime":"0","endTime":"0","summary":"BTIG raised the firm’s price target on Praxis Precision (PRAX) to $826 from $810 and keeps a Buy rating on the shares. With relutrigine’s December ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/praxis-precision-price-target-raised-to-826-from-810-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/praxis-precision-price-target-raised-to-826-from-810-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BFTCPJ56.SGD","IE0002141913.USD","BK4139","IE00B2B36J28.USD","LU0109394709.USD","LU0889565916.HKD","IBRN","LU0320765992.SGD","IE00BJT1NW94.SGD","IE0009355771.USD","PRAX","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673058928","title":"Praxis Precision Med is Maintained at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2673058928","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673058928?lang=en_us&edition=fundamental","pubTime":"2026-10-06 18:17","pubTimestamp":1791281820,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRAX/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","IE0009355771.USD","IE00B4R5TH58.HKD","LU0109394709.USD","BK4139","IE0002141913.USD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","IBRN","IE00BJJMRZ35.SGD","PRAX","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672746732","title":"Praxis Precision Medicines Grants 3,478 Inducement RSUs to 14 New Employees Under 2024 Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2672746732","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672746732?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:01","pubTimestamp":1790971276,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines grants 3,478 inducement RSUs to 14 new employees under 2024 planPraxis Precision Medicines granted restricted stock units covering 3,478 common shares to 14 new non-executiv","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL8n5PWp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE0009355771.USD","IE00BQXX3D17.EUR","IE00B64PRP62.GBP","IE00BJT1NW94.SGD","IE00BQXX3C00.GBP","LU0109394709.USD","IE00B2B36J28.USD","IE00BGHQF748.EUR","IE00BJJMRZ35.SGD","LU0314104364.USD","BCDF","BK4585","IE00BN0W2W23.USD","SG9999014005.SGD","SG9999014013.SGD","IE00B3QW5Z07.USD","IE00BQXX3F31.USD","LU0889565916.HKD","LU0320765992.SGD","IE00B4R5TH58.HKD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","LU2210149790.SGD","IE00BFTCPJ56.SGD","SG9999014021.USD","IBRN","LU2095319765.USD","BK4112","LU2210150020.SGD","PRAX","IE0002141913.USD","BK4588","NDAQ","SG9999014039.USD","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672749918","title":"Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672749918","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672749918?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:01","pubTimestamp":1790971260,"startTime":"0","endTime":"0","summary":"Investor Contact:. 857-702-9452. Media Contact:. Dan Ferry. LifeSci Advisors. 617-430-7576","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/02/3374007/0/en/praxis-precision-medicines-inc-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","BK4200","BK4561","LU0889565916.HKD","BK4139","IE00B2B36J28.USD","LU0320765992.SGD","IBRN","ASO","IE0009355771.USD","IE0002141913.USD","IE00BJT1NW94.SGD","PRAX","IE00BJJMRZ35.SGD","CNS","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LCLG","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672379110","title":"Praxis Precision Medicines, Inc. : Jonestrading Raises Target Price to $534 from $441","url":"https://stock-news.laohu8.com/highlight/detail?id=2672379110","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672379110?lang=en_us&edition=fundamental","pubTime":"2026-10-02 12:50","pubTimestamp":1790916618,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O04U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0109394709.USD","BK4139","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","IBRN","IE00B2B36J28.USD","LU0320765992.SGD","IE00BJT1NW94.SGD","LU0889565916.HKD","IE0009355771.USD","IE0002141913.USD","PRAX","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672991762","title":"Analyst Justin Walsh Reiterates Buy on Praxis as Upgraded Relutrigine Forecast Triples Long-Term Revenue Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2672991762","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672991762?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:35","pubTimestamp":1790886921,"startTime":"0","endTime":"0","summary":"JonesTrading analyst Justin Walsh has reiterated their bullish stance on PRAX stock, giving a Buy rating on September 24. Justin Walsh has given hi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-justin-walsh-reiterates-buy-on-praxis-as-upgraded-relutrigine-forecast-triples-long-term-revenue-potential-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-justin-walsh-reiterates-buy-on-praxis-as-upgraded-relutrigine-forecast-triples-long-term-revenue-potential-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD","BK4139","IE00B2B36J28.USD","IBRN","LU0889565916.HKD","LU0109394709.USD","IE00BJT1NW94.SGD","PRAX","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669464161","title":"Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), Oruka Therapeutics (ORKA) and Harmony Biosciences Holdings (HRMY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669464161","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669464161?lang=en_us&edition=fundamental","pubTime":"2026-09-24 18:30","pubTimestamp":1790245831,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Praxis Precision Medicines (PRAX), Oruka Therapeutic...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-praxis-precision-medicines-prax-oruka-therapeutics-orka-and-harmony-biosciences-holdings-hrmy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-praxis-precision-medicines-prax-oruka-therapeutics-orka-and-harmony-biosciences-holdings-hrmy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","IE00BFTCPJ56.SGD","LU0109394709.USD","BK4139","LU0889565916.HKD","BK4007","XBI","HRMY","BK4137","BK4585","HCSG","ORKA","XLV","IBRN","IE00B4R5TH58.HKD","BK4581","IE00BJJMRZ35.SGD","LU0128526141.USD","IE0002141913.USD","IE00BJT1NW94.SGD","LU0029874061.USD","IE00B2B36J28.USD","PRAX","LABU","BK4588","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669613784","title":"Analyst Reiterates Buy on PRAX with Unchanged $582 Price Target Ahead of Key Phase 3 EMERALD Trial for Relutrigine","url":"https://stock-news.laohu8.com/highlight/detail?id=2669613784","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669613784?lang=en_us&edition=fundamental","pubTime":"2026-09-24 17:55","pubTimestamp":1790243718,"startTime":"0","endTime":"0","summary":"In a report released today, Ami Fadia from Needham reiterated a Buy rating on Praxis Precision Medicines, with a price target of $582.00. Ami Fadia...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-prax-with-unchanged-582-price-target-ahead-of-key-phase-3-emerald-trial-for-relutrigine-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-prax-with-unchanged-582-price-target-ahead-of-key-phase-3-emerald-trial-for-relutrigine-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRAX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.praxismedicines.com","stockEarnings":[{"period":"1week","weight":0.0117},{"period":"1month","weight":-0.047},{"period":"3month","weight":-0.0805},{"period":"6month","weight":-0.1607},{"period":"1year","weight":0.4391},{"period":"ytd","weight":-0.0921}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":-0.0022},{"period":"3month","weight":0.0551},{"period":"6month","weight":0.071},{"period":"1year","weight":0.1232},{"period":"ytd","weight":0.1287}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. It is developing ulixacaltamide, a small molecule inhibitor of T-type calcium channels that is in Phase IIb clinical trial for the treatment of essential tremor, as well as in Phase II clinical trial to treat Parkinson's disease; PRAX-562 for the treatment of pediatric patients with developmental and epileptic encephalopathies (DEE); and PRAX-628 to treat focal epilepsy. The company also develops PRAX-222 for the treatment of pediatric patients with early-onset SCN2A-DEE; PRAX-020 to treat KCNT1 related epilepsies; PRAX-080 for the treatment of PCDH19; and PRAX-090 and PRAX-100 for SYNGAP1 and SCN2A-LoF. It has a license agreement with RogCon Inc.; a research collaboration and license agreement with Ionis Pharmaceuticals, Inc.; a strategic collaboration and license agreement with UCB Biopharma SRL; and collaboration with The Florey Institute to develop three novel ASOs. Praxis Precision Medicines, Inc. was incorporated in 2015 and is based in Boston, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.298328},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.166549},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.160217},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.017086},{"month":5,"riseRate":0.5,"avgChangeRate":-0.087139},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.085881},{"month":7,"riseRate":0.5,"avgChangeRate":0.12656},{"month":8,"riseRate":0.5,"avgChangeRate":0.090189},{"month":9,"riseRate":0.5,"avgChangeRate":-0.016807},{"month":10,"riseRate":0.5,"avgChangeRate":0.413417},{"month":11,"riseRate":0.666667,"avgChangeRate":0.073478},{"month":12,"riseRate":0.833333,"avgChangeRate":0.206625}],"exchange":"NASDAQ","name":"Praxis Precision Medicines, Inc.","nameEN":"Praxis Precision Medicines, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Praxis Precision Medicines, Inc.(PRAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Praxis Precision Medicines, Inc.(PRAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Praxis Precision Medicines, Inc.,PRAX,Praxis Precision Medicines, Inc.股票,Praxis Precision Medicines, Inc.股票老虎,Praxis Precision Medicines, Inc.股票老虎国际,Praxis Precision Medicines, Inc.行情,Praxis Precision Medicines, Inc.股票行情,Praxis Precision Medicines, Inc.股价,Praxis Precision Medicines, Inc.股市,Praxis Precision Medicines, Inc.股票价格,Praxis Precision Medicines, Inc.股票交易,Praxis Precision Medicines, Inc.股票购买,Praxis Precision Medicines, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Praxis Precision Medicines, Inc.(PRAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Praxis Precision Medicines, Inc.(PRAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}